LBX2

mutation — cross-omics
Cross-omicsMUTATION → IMMUNEPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, LBX2 mutation is significantly associated with the immune_cell of many other genes, with 4 significant associations in total. COAD shows the largest number of these associations.

The most reproducible LBX2-associated genes across cancer lineages are CD8+ T-cells, CD4+ naive T-cells, and CD8+ Tcm. Each is linked with LBX2 in more than 1 cancer types. Because this analysis shows association rather than direction, both LBX2-to-partner and partner-to-LBX2 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CD8+ T-cells grouped by LBX2-low versus LBX2-high in COAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (LBX2→partner) and Y-score (partner→LBX2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
COADCD8+ T-cells →+0.059+5.142<.001.04132
COADCD4+ naive T-cells →+0.031+5.142<.001.04132
COADCD8+ Tcm →+0.101+4.917<.001.04831
UCECCD8+ Tem →+0.005+5.258<.001.02931
Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

CD8+ T-cells by LBX2 expression — COAD

Box plot of CD8+ T-cells in LBX2-low vs LBX2-high samples in COAD.

Explore this box plot interactively →

Exploration